Florence Lebon

780 total citations
21 papers, 615 citations indexed

About

Florence Lebon is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Florence Lebon has authored 21 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Florence Lebon's work include HIV/AIDS drug development and treatment (6 papers), Metal complexes synthesis and properties (5 papers) and Receptor Mechanisms and Signaling (5 papers). Florence Lebon is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Metal complexes synthesis and properties (5 papers) and Receptor Mechanisms and Signaling (5 papers). Florence Lebon collaborates with scholars based in Belgium, France and United Kingdom. Florence Lebon's co-authors include Tom Ceska, Zara A. Sands, F. Durant, Tong Sun Kobilka, Martyn Wood, Bingfa Sun, Brian K. Kobilka, Joël Mercier, Matthew Chu and Michèle Reboud‐Ravaux and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Florence Lebon

21 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Lebon Belgium 15 282 170 103 99 98 21 615
Bethany L. Kormos United States 18 475 1.7× 150 0.9× 180 1.7× 107 1.1× 42 0.4× 25 814
Kaspar Zimmermann Switzerland 16 663 2.4× 139 0.8× 263 2.6× 84 0.8× 110 1.1× 24 1.0k
Salvatore Bongarzone United Kingdom 16 315 1.1× 42 0.2× 157 1.5× 51 0.5× 48 0.5× 39 921
Andy Merritt United Kingdom 15 430 1.5× 95 0.6× 224 2.2× 13 0.1× 71 0.7× 32 816
D. Andrew Stevenson United States 15 214 0.8× 154 0.9× 80 0.8× 85 0.9× 131 1.3× 20 761
Matej Repič Slovenia 11 261 0.9× 71 0.4× 136 1.3× 44 0.4× 18 0.2× 13 552
Steven C. Koerber United States 22 690 2.4× 196 1.2× 77 0.7× 40 0.4× 78 0.8× 42 1.1k
Bruce W. Surber United States 17 359 1.3× 62 0.4× 242 2.3× 10 0.1× 238 2.4× 36 1.2k
Michel Maillard United States 12 366 1.3× 103 0.6× 191 1.9× 22 0.2× 34 0.3× 16 698
Aleksandra Živković Germany 19 454 1.6× 61 0.4× 126 1.2× 17 0.2× 29 0.3× 46 761

Countries citing papers authored by Florence Lebon

Since Specialization
Citations

This map shows the geographic impact of Florence Lebon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Lebon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Lebon more than expected).

Fields of papers citing papers by Florence Lebon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Lebon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Lebon. The network helps show where Florence Lebon may publish in the future.

Co-authorship network of co-authors of Florence Lebon

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Lebon. A scholar is included among the top collaborators of Florence Lebon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Lebon. Florence Lebon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Bingfa, Dan Feng, Matthew Ling-Hon Chu, et al.. (2021). Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist. Nature Communications. 12(1). 3305–3305. 37 indexed citations
2.
Sun, Bingfa, Matthew Chu, Martyn Wood, et al.. (2017). Crystal structure of the adenosine A2Areceptor bound to an antagonist reveals a potential allosteric pocket. Proceedings of the National Academy of Sciences. 114(8). 2066–2071. 101 indexed citations
3.
Daniëls, Veronique, et al.. (2015). Exploring the Interaction of SV2A with Racetams Using Homology Modelling, Molecular Dynamics and Site-Directed Mutagenesis. PLoS ONE. 10(2). e0116589–e0116589. 24 indexed citations
4.
Benoit, Roger, Daniel Frey, Manuel Hilbert, et al.. (2013). Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Nature. 505(7481). 108–111. 102 indexed citations
5.
Tetko, Igor V., Sergii Novotarskyi, Iurii Sushko, et al.. (2013). Development of Dimethyl Sulfoxide Solubility Models Using 163 000 Molecules: Using a Domain Applicability Metric to Select More Reliable Predictions. Journal of Chemical Information and Modeling. 53(8). 1990–2000. 48 indexed citations
6.
Lebon, Florence, B. Mathieu, Dhurke Kashinath, et al.. (2012). Towards a KCC2 blocker pharmacophore model. Bioorganic & Medicinal Chemistry Letters. 22(12). 3978–3982. 2 indexed citations
7.
Shi, Jiye, et al.. (2011). Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding. Biochemical Society Transactions. 39(5). 1341–1347. 27 indexed citations
8.
Wijtmans, Maikel, Sylvain Célanire, Erwin Snip, et al.. (2008). 4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H3Receptor Agonists. Journal of Medicinal Chemistry. 51(10). 2944–2953. 20 indexed citations
9.
Lambeng, Nathalie, Florence Lebon, B. Christophe, et al.. (2006). Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: Identification of a lead and initial SAR studies. Bioorganic & Medicinal Chemistry Letters. 17(1). 272–277. 14 indexed citations
10.
Provins, Laurent, et al.. (2006). First dual M3 antagonists-PDE4 inhibitors: Synthesis and SAR of 4,6-diaminopyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 16(7). 1834–1839. 30 indexed citations
11.
Lebon, Florence, et al.. (2003). Modeling of Copper(II) Complexes with the SIBFA Polarizable Molecular Mechanics Procedure. Application to a New Class of HIV-1 Protease Inhibitors. The Journal of Physical Chemistry B. 107(38). 10640–10652. 27 indexed citations
12.
Lebon, Florence, Nicole Boggetto, F. Durant, et al.. (2002). Metal-organic compounds: a new approach for drug discovery. Biochemical Pharmacology. 63(10). 1863–1873. 53 indexed citations
13.
Meskens, Nadine, et al.. (2002). Multivariate Analysis and Rough Sets: Two Approaches for Software‐quality Analysis. International Transactions in Operational Research. 9(3). 353–369. 1 indexed citations
14.
Lebon, Florence. (2001). Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide. Journal of Inorganic Biochemistry. 86(2-3). 547–554. 16 indexed citations
15.
Lebon, Florence, et al.. (2000). Approaches to the Design of Effective HIV-1 Protease Inhibitors. Current Medicinal Chemistry. 7(4). 455–477. 46 indexed citations
16.
Lebon, Florence, Eve de Rosny, Michèle Reboud‐Ravaux, & F. Durant. (1998). De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor. European Journal of Medicinal Chemistry. 33(9). 733–737. 12 indexed citations
17.
Duhault, J, et al.. (1974). Microangiopathie diabétique: étude comparative chez l’homme et l’animal1. Biorheology. 11(3). 167–178. 6 indexed citations
18.
Boulanger, M., et al.. (1973). [Experimental diabetic microangiopathy].. PubMed. 2(45). 3013–7. 4 indexed citations
19.
Lebon, Florence, et al.. (1973). KK mice as a model of microangiopathic lesions in diabetes.. PubMed. 11. 453–8. 18 indexed citations
20.
Lebon, Florence, et al.. (1972). The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.. PubMed. 22(10). 1686–90. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bethany L. Kormos Breakdown of academic impact, for papers by Kaspar Zimmermann Breakdown of academic impact, for papers by Salvatore Bongarzone Breakdown of academic impact, for papers by Andy Merritt Breakdown of academic impact, for papers by D. Andrew Stevenson Breakdown of academic impact, for papers by Matej Repič Breakdown of academic impact, for papers by Steven C. Koerber Breakdown of academic impact, for papers by Bruce W. Surber Breakdown of academic impact, for papers by Michel Maillard Breakdown of academic impact, for papers by Aleksandra Živković
Rankless by CCL
2026